Skip to main content

Ask Check my drug Drugs Grants Find by condition Learn

Home / Manufacturers / Boehringer Ingelheim and Eli Lilly

Boehringer Ingelheim and Eli Lilly

Under review·Mar 16, 2026

Drugs from Boehringer Ingelheim and Eli Lilly (1)

ZOLYMBUS
bimatoprost

Newsletter

Drug approvals + grants + policy. Bi-weekly. No ads.

Email address

Double opt-in · unsubscribe anytime · see what’s included

RxCopays

Free prescription copay help for patients. Verified against primary sources.

Navigate

Drugs
Travel grants
Prior authorization
Manufacturers
Conditions
Interactions
Ask RxCopays
Learn

Trust & methodology

Accuracy policy
About
Report an error
Privacy
Partnerships

Primary sources

openFDA NDC Directory
NLM DailyMed
CMS Part D formulary (SPUF)
Manufacturer copay portals

© 2026 RxCopays. Not medical advice — confirm copay terms with your pharmacy or plan before relying on any number shown here.

Sister site: UniteRare.org · rare disease navigation